Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma, Surendra K; Sharma, Anju; Kadhiravan, Tamilarasu; Tharyan, Prathap.
Cochrane Database Syst Rev
; (7): CD007545, 2013 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-23828580
Six-month therapy for abdominal tuberculosis.
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.
Rifabutin for treating pulmonary tuberculosis.
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Treatment of latent tuberculosis infection: a network meta-analysis.